Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, December 21, 2023
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
Wed, December 20, 2023
[ Wed, Dec 20th 2023
] - WOPRAI
[ Wed, Dec 20th 2023
] - WOPRAI
Charles Duncan Reiterated (AXSM) at Buy and Held Target at $108 on, Dec 20th, 2023
Charles Duncan of Cantor Fitzgerald, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Buy and Held Target at $108 on, Dec 20th, 2023.
Charles has made no other calls on AXSM in the last 4 months.
There are 3 other peers that have a rating on AXSM. Out of the 3 peers that are also analyzing AXSM, 0 agree with Charles's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Charles
- David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $125 on, Wednesday, December 13th, 2023
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Tuesday, December 12th, 2023
- Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $100 on, Monday, September 25th, 2023
